Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Agenus USD 15.05M 656K 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Ardelyx USD -30.68M 35.78M 2026-03
aTyr Pharma USD -121.47K 24.59M 2026-03
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Celldex Therapeutics USD -80.62M 3.81M 2026-06
Curis USD -11.52M 3.64M 2026-03
Eli Lilly USD 12.46B 2.68B 2026-06
Incyte USD 700.4M 356.23M 2026-06
MacroGenics USD -31.88M 19.79M 2026-03
Novartis USD 4.73B 549M 2026-06
Novartis USD 4.18B 118M 2026-03
Pfizer USD -180M 5.16B 2026-06
Prothena USD 25.79M 53M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06